Related Experiment Video
Updated: Jul 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Continuous Glucose Monitoring in Glycogen Storage Diseases: A Systematic Review of Clinical Utility, Accuracy and
Reihaneh Mohsenipour1, Farzaneh Abbasi1, Maryam Sadat Ghaderian2
1Growth and Development Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Background:
Achieving euglycemia in Glycogen Storage Diseases (GSD) depends on strict dietary adherence; however, intermittent monitoring frequently fails to detect rapid hypoglycemic excursions. This systematic review evaluates the clinical utility, accuracy and psychosocial impact of Continuous Glucose Monitoring (CGM) across hepatic GSD subtypes.
Methods:
We searched PubMed, Embase, Scopus, Web of Science and Cochrane Library (inception to December 2025) following PRISMA 2020 guidelines. Eligible studies included randomized trials, cohorts and case series reporting CGM outcomes in hepatic GSD.
Results:
Thirty-one studies (N = 323) met inclusion criteria, predominantly GSD Ia, Ib and III. CGM consistently identified asymptomatic hypoglycemia, with adult cohorts spending up to 12% of time below range (< 70 mg/dL) despite normal spot checks. In interventional settings, CGM-guided dietary titration improved Time in Range (e.g., 72%-86% in gene therapy trials) and reduced serum triglycerides and liver size. However, sensor performance showed a positive bias in the hypoglycemic range, potentially masking severe neuroglycopenia. Psychosocially, while CGM improved sleep quality scores, it introduced 'alarm fatigue' from false-positive alerts.
Conclusion:
Emerging evidence suggests that CGM may shift GSD management from reactive treatment to proactive stabilization. It offers superior sensitivity for detecting occult hypoglycemia and guiding therapy, though its utility is tempered by sensor inaccuracy at lower limits and the burden of constant surveillance. Future implementation requires subtype-specific interpretation and sensors optimized for the hypoglycemic range.
Related Concept Videos
Hypoglycemia and Glucagon
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
